Log in
Login
Password
Remember
Lost password
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Shares  >  Swiss Exchange  >  Novartis AG    NOVN

 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Swiss Exchange
07/27/2015 07/28/2015 07/29/2015 07/30/2015 07/31/2015 Date
97.85(c) 98.85(c) 100.2(c) 100(c) 100.4(c) Last
4 855 032 4 157 094 5 646 866 2 924 653 4 064 383 Volume
-0.81% +1.02% +1.37% -0.20% +0.40% Change
More quotes
Financials ($)
Sales 2015 51 693 M
EBIT 2015 14 441 M
Net income 2015 12 374 M
Debt 2015 6 800 M
Yield 2015 2,71%
Sales 2016 52 972 M
EBIT 2016 13 961 M
Net income 2016 10 708 M
Debt 2016 4 942 M
Yield 2016 2,87%
PER 2015 18,16
PER 2016 23,29
EV / Sales 2015 5,50x
EV / Sales 2016 5,33x
Capitalization 277 369 M
More Financials
Company
Novartis AG develops, manufactures, and markets healthcare products.It operates through the following segments: Pharmaceuticals, Alcon, Sandoz, Vaccines and Diagnostics, and Consumer Health.The Pharmaceuticals segment provides patent-protected prescription medicines.The Alcon segment offers... 
Sector
Pharmaceuticals
Calendar
09/17Presentation
More about the company
Surperformance© ratings of Novartis AG
Trading Rating : Investor Rating :
More Ratings
Latest news on NOVARTIS AG
07/31 Diageo announces changes to its Board of Directors
07/31 NOVARTIS : $76,645 Federal Contract Awarded to Alcon Laboratories
07/31 NOVARTIS : Alcon Research Assigned Patent
07/31 CSL : Update on Novartis influenza vaccines acquisition
07/30DJAmgen Raises 2015 Outlook, Results Beat Expectations -- 2nd Update
07/30DJAmgen Raises 2015 Outlook, Results Beat Expectations
07/30 Teva's MS drug Copaxone has strong second-quarter sales
07/30 NOVARTIS : Mereo BioPharma Acquires Clinical Assets from Novartis
More news
Sector news : Pharmaceuticals - NEC
08/01 ALLERGAN : BRIEF: Teva secures $34b financing for Allergan acquisition
07/31 HOSPIRA : Citing vulnerability to hacking, FDA says hospitals should stop using ..
07/31 HOSPIRA : Citing hacking risk, FDA says Hospira pump shouldn't be used
More sector news : Pharmaceuticals - NEC
News from SeekingAlpha
07/31 THERAVANCE : On Track To Deliver Rising Dividends
07/31 Tracking Ken Fisher's Fisher Asset Management Portfolio - Q2 2015 Update
07/30 PREMARKET BIOTECH DIGEST : Familial Hypercholesterolemia, Dynavax BLA Track, Ear..
07/30 Tracking Kahn Brothers Portfolio - Q2 2015 Update
07/29 Novartis spins off three investigational products to Mereo BioPharma


Comments 
Advertisement
Chart NOVARTIS AG
Duration : Period :
Novartis AG Technical Analysis Chart | NOVN | CH0012005267 | 4-Traders
Full-screen chart
Technical analysis trends NOVARTIS AG
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions